CLC bio releases Version 4.5 of CLC Genomics Workbench

NewsGuard 100/100 Score

Today, CLC bio announced the release of CLC bio's premier desktop software package for working with genomics, transcriptomics, and epigenomics: Version 4.5 of CLC Genomics Workbench - an update which gives molecular biologists access to analyze high-througput sequencing datasets with powerful bioinformatics algorithms through a user-friendly graphical user-interface.

"Our RNA-seq analysis now supports the use of paired-end data for RNA-seq. A combination of single reads and paired reads can also be used, and expression values can now be stratified into transcript level expression values, both for single and paired reads, allowing users to compare two different samples across transcripts." elaborates Solution Delivery Manager at CLC bio, Søren Mønsted, and continues, "Another important new feature is our batching functionality of all our high-throughput sequencing tools, enabling researchers to perform the same analysis on several elements in one batch, which is an easy way to analyze multiple datasets in one go and thereby save time for setting up and running the same type of analysis multiple times."

Other important additions to CLC Genomics Workbench 4.5 include redesigned multiplexing and BLAST tools, as well as a new algorithm for mapping SOLiD reads, among other features.

Launched in 2008, CLC Genomics Workbench is the first integrated analysis solution for comprenhensive genomics, transcriptomics, and epigenomics analyses. CLC Genomics Workbench can analyze and visualize large datasets from all major high-throughput sequencing platforms: Illumina, SOLiD, and 454 by Roche, in addition to traditional Sanger sequence data. Like all desktop applications from CLC bio, CLC Genomics Workbench is platform independent, running on Mac OS X, Windows, and Linux - including 64bit versions.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tumor microbiomes offer new insights for enhancing cancer therapies